Inventor · disambiguated record
Raghava Reddy Kethiri
Also filed as: KETHIRI RAGHAVA · KETHIRI RAGHAVA REDDY
15 granted patents·8 pending applications·16 citations·filing 2012–2025
89Inventor score
Files withASANA BIOSCIENCES LLC11GLAXOSMITHKLINE IP DEV LTD5BIOIMICS AB2APTOSE BIOSCIENCES INC1ENDO PHARMACEUTICALS INC1
Top patents by PatentIndex Score
23 records- 0190US11103491B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2020·Granted Aug 31, 2021·2 cites·12 claims
- 0285US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 0384US11547704B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 10, 2023·1 cites·4 claims
- 0484US10751332B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Aug 25, 2020·2 cites·7 claims
- 0582US10471051B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2017·Granted Nov 12, 2019·3 cites·38 claims
- 0682US9896445B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Feb 20, 2018·3 cites·27 claims
- 0776US11925629B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2021·Granted Mar 12, 2024·0 cites·14 claims
- 0874US2023165848A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 0972US10851053B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Dec 1, 2020·1 cites·4 claims
- 1069US9371316B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 21, 2016·0 cites·18 claims
- 1169US9266873B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2014·Granted Feb 23, 2016·0 cites·10 claims
- 1265US9533981B2Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2013·Granted Jan 3, 2017·0 cites·21 claims
- 1363US11130741B2Anti-infective heterocyclic compounds and uses thereofBIOIMICS AB·Filed 2017·Granted Sep 28, 2021·1 cites·20 claims
- 1460US2017073339A1Pyridine derivativesASANA BIOSCIENCES LLC·Filed 2016·Application pending·0 cites
- 1552US2016222014A1Compounds for regulating fak and/or src pathwaysASANA BIOSCIENCES LLC·Filed 2014·Application pending·0 cites
- 1652US2019298705A1Chemical CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1751US2025206714A1Compositions and methods for treatment of inflammatory diseasesINVEA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1849US9199975B2Biaryl imidazole derivatives for regulating CYP17ASANA BIOSCIENCES LLC·Filed 2012·Granted Dec 1, 2015·0 cites·18 claims
- 1944US2019241573A1Isoquinoline derivatives as perk inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 2041US10273224B2Substituted pyrimidine compounds, compositions and medicinal applications thereofJUBILANT BIOSYS LTD·Filed 2014·Granted Apr 30, 2019·0 cites·7 claims
- 2136US2018237441A1Chemical CompoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
- 2233US11279703B2Fused pyrimidine compounds as BRD4 and JAK2 dual inhibitors and methods for use thereofAPTOSE BIOSCIENCES INC·Filed 2017·Granted Mar 22, 2022·0 cites·10 claims
- 2332US2021246115A1Anti-infective heterocyclic compounds and uses thereofBIOIMICS AB·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raghava Reddy Kethiri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →